clioquinol has been researched along with Angiogenesis, Pathologic in 3 studies
Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SY | 1 |
| Lee, MJ | 1 |
| Kim, JW | 1 |
| Na, YR | 1 |
| Lee, HY | 1 |
| Cho, H | 1 |
| Lee, KB | 1 |
| Lee, YM | 1 |
| Lee, C | 1 |
| Park, H | 1 |
| Yang, EG | 1 |
| Daniel, KG | 1 |
| Chen, D | 2 |
| Yan, B | 2 |
| Dou, QP | 2 |
| Cui, QC | 1 |
| Yang, H | 1 |
| Barrea, RA | 1 |
| Sarkar, FH | 1 |
| Sheng, S | 1 |
| Reddy, GP | 1 |
1 review available for clioquinol and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Copper-binding compounds as proteasome inhibitors and apoptosis inducers in human cancer.
Topics: Antineoplastic Agents; Apoptosis; Clioquinol; Copper; Humans; Neoplasms; Neovascularization, Patholo | 2007 |
2 other studies available for clioquinol and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Effects of clioquinol analogues on the hypoxia-inducible factor pathway and intracelullar mobilization of metal ions.
Topics: Animals; Biological Transport; Blood Vessels; Cations, Divalent; Cell Hypoxia; Chick Embryo; Chorioa | 2012 |
Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
Topics: Androgen Receptor Antagonists; Animals; Apoptosis; Cell Line, Tumor; Clioquinol; Copper; Humans; Mal | 2007 |